A nomogram for predicting cause-specific mortality among patients with cecal carcinoma: a study based on SEER database
- PMID: 37221487
- PMCID: PMC10207820
- DOI: 10.1186/s12876-023-02802-7
A nomogram for predicting cause-specific mortality among patients with cecal carcinoma: a study based on SEER database
Abstract
Objective: Classical Cox proportional hazard models tend to overestimate the event probability in a competing risk setup. Due to the lack of quantitative evaluation of competitive risk data for colon cancer (CC), the present study aims to evaluate the probability of CC-specific death and construct a nomogram to quantify survival differences among CC patients.
Methods: Data on patients diagnosed with CC between 2010 and 2015 were collected from the Surveillance, Epidemiology, and End Results Program (SEER) database. Patients were divided into a training dataset for the establishment of the model and a validation dataset to evaluate the performance the model at a ratio of 7:3. To evaluate the ability of multiple variables to predict cause-specific death in CC patients, univariate and multivariate analyses with Fine-Gray models were performed to screen the predictors of cause-specific death, and a nomogram for predicting cause-specific mortality was constructed. Then, the receiver operating characteristic (ROC) curve and the calibration curve were plotted to evaluate the prognostic performance of the nomogram.
Results: The dataset was randomly divided into a training (n = 16,655) dataset and a validation (n = 7,139) dataset at a ratio of 7:3. In the training dataset, variables including pathological subtypes of tumors, pathological grading (degree of differentiation), AJCC staging, T-staging, surgical type, lymph node surgery, chemotherapy, tumor deposits, lymph node metastasis, liver metastasis, and lung metastasis were identified as independent risk factors for cause-specific death of CC patients. Among these factors, the AJCC stage had the strongest predictive ability, and these features were used to construct the final model. In the training dataset, the consistency index (C-index) of the model was 0.848, and the areas under the receiver operating characteristic curve (AUC) at 1, 3, and 5 years was 0.852, 0.861, and 0.856, respectively. In the validation dataset, the C-index of the model was 0.847, and the AUC at 1 year, 3 years, and 5 years was 0.841, 0.862, and 0.852, respectively, indicating that this nomogram had an excellent and robust predictive performance.
Conclusion: This study can help clinical doctors make better clinical decisions and provide better support for patients with CC.
Keywords: CC; Cause-specific mortality; Competing risk model; SEER database.
© 2023. The Author(s).
Conflict of interest statement
The authors declared no competing interests.
Figures





Similar articles
-
Development and validation of a nomogram model for cancer-specific survival of patients with poorly differentiated thyroid carcinoma: A SEER database analysis.Front Endocrinol (Lausanne). 2022 Sep 13;13:882279. doi: 10.3389/fendo.2022.882279. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36176465 Free PMC article. Clinical Trial.
-
A prognostic nomogram for the cancer-specific survival of patients with upper-tract urothelial carcinoma based on the Surveillance, Epidemiology, and End Results Database.BMC Cancer. 2020 Jun 8;20(1):534. doi: 10.1186/s12885-020-07019-5. BMC Cancer. 2020. PMID: 32513124 Free PMC article.
-
Bladder cancer survival nomogram: Development and validation of a prediction tool, using the SEER and TCGA databases.Medicine (Baltimore). 2019 Nov;98(44):e17725. doi: 10.1097/MD.0000000000017725. Medicine (Baltimore). 2019. PMID: 31689813 Free PMC article.
-
Development and validation of a Surveillance, Epidemiology, and End Results (SEER)-based prognostic nomogram for predicting survival in gastric cancer with multi-organ metastases.Transl Cancer Res. 2022 Jun;11(6):1534-1551. doi: 10.21037/tcr-21-2569. Transl Cancer Res. 2022. PMID: 35836507 Free PMC article.
-
The nomograms for predicting overall and cancer-specific survival in elderly patients with early-stage lung cancer: A population-based study using SEER database.Front Public Health. 2022 Sep 8;10:946299. doi: 10.3389/fpubh.2022.946299. eCollection 2022. Front Public Health. 2022. PMID: 36159305 Free PMC article. Clinical Trial.
References
-
- Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H, Dicker DJ, Chimed-Orchir O, Dandona R, Dandona L, et al. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol. 2017;3(4):524–548. doi: 10.1001/jamaoncol.2016.5688. - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources